Cargando…
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients
BACKGROUND: Pancreatic cancer (PC) is a malignancy with a poor prognosis and high mortality. Surgical resection is the only “curative” treatment. However, only a minority of patients with PC can obtain surgery. Improving the overall survival (OS) rate of patients with PC is still a major challenge....
Autores principales: | Li, Wei, Li, Tiandong, Sun, Chenguang, Du, Yimeng, Chen, Linna, Du, Chunyan, Shi, Jianxiang, Wang, Weijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013045/ https://www.ncbi.nlm.nih.gov/pubmed/35428170 http://dx.doi.org/10.1186/s10020-022-00467-8 |
Ejemplares similares
-
Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma
por: Wu, Zonglong, et al.
Publicado: (2022) -
A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma
por: Li, Tiandong, et al.
Publicado: (2023) -
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
por: Cheng, Yang, et al.
Publicado: (2019) -
Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma
por: Li, Hanyu, et al.
Publicado: (2019) -
Immunocyte Infiltration Analysis and Immunohistochemistry Identify EVL as a Potential Prognostic Biomarker for Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023)